trial
as of 2026-07-01Source-monitoring & Psychosis
NCTId NCT04236531
at a glance
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Unknown
Enrollment
90 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2021-05-17
Primary completion
2023-10
Eligibility
ALL · 18 Years · 30 Years
Interventions & indications
Indications
Sponsors
Hôpital le VinatierLead Sponsor
Sites
2 total
Bron, FranceBron, France
Facts & assertions
4 sourced
Enrollment
90
Phase
NA
Primary Completion Date
2023-10
Status
UNKNOWN
relationships
The graph out of here
drug
lead_sponsor
company
indication
indication
indication